DVLA £1,000 driving fine risk over 209 medical conditions
The DVLA tells motorists there are multiple conditions they may need to declare to avoid the risk of breaking the rules
UK drivers are being cautioned that they must inform officials about medical conditions that could affect their driving. The DVLA (Driver and Vehicle Licensing Agency) warns that failure to disclose one of 209 conditions could result in a fine of up to £1,000.
The DVLA suggests that if you have one of the listed conditions, you might even consider voluntarily surrendering your licence. This might be an option for those who have been advised by their doctor to refrain from driving for three months or more.
You might also consider this if your medical condition compromises your ability to drive safely for a period of three months or longer. Or you might need to do this if your medical condition means you do not meet the necessary standards for driving.
If you decide to take this step, the DVLA says: "You'll need to tell DVLA and send them your licence. If you have a medical condition that affects your driving and do not voluntarily give up your licence, you must inform DVLA. They will decide if you can continue holding a driving licence."
Medical conditions you may need to declare to the DVLA - full list
The list of 209 conditions here applies to those with a car. If you have a bus, lorry or coach licence, "you cannot use the online service to check for your condition or report it to DVLA", they add.
Check the guidance on seizures and epilepsy Check the guidance on acoustic neuroma Check the guidance on Addison's disease Check the guidance on agoraphobia Check the guidance on alcohol problems Check the guidance on Alzheimers disease Check the guidance on transient ischaemic attacks and mini-strokes Check the guidance on amputations Check the guidance on motor neuron disease - also known as ALS Check the guidance on angina Check the guidance on heart attacks and angioplasty Check the guidance on ankylosing spondylitis Check the guidance on eating disorders
Check the guidance on anxiety Check the guidance on aortic aneurysms Check the guidance on arachnoid cysts
Check the guidance on arrhythmias Check the guidance on defibrillators Check the guidance on arteriovenous malformations
Check the guidance on arthritis Check the guidance on autistic spectrum condition, including asperger syndrome Check the guidance on ataxia, including Friedrich's ataxia
Check the guidance on ADHD Check the guidance on autistic spectrum condition, including asperger syndrome
B
Check the guidance on balloon angioplasties in the leg
Check the guidance on bipolar disorder - previously known as manic depression Check the guidance on blackouts and fainting Check the guidance on eye conditions
Check the guidance on blood clots Check the guidance on blood pressure Check the guidance on brachial plexus injuries
Check the guidance on brain abscesses, cysts or encephalitis Check the guidance on brain aneurysms Check the guidance on angiomas
Check the guidance on brain haemorrhages Check the guidance on traumatic brain injuries Check the guidance on brain tumours
Check the guidance on broken limbs Check the guidance on Brugada syndrome Check the guidance on burr hole surgery
C
Check the guidance on surgery Check the guidance on cancer (not including leukaemia) Check the guidance on eye conditions
Check the guidance on catheter ablations Check the guidance on cardiac problems Check the guidance on carotid artery stenosis
Check the guidance on cataplexy Check the guidance on cavernomas Check the guidance on central venous thrombosis
Check the guidance on cerebral palsy Check the guidance on Charcot-Marie-Tooth disease Check the guidance on Chiari malformation
Check the guidance on chronic aortic dissection Check the guidance on cognitive problems Check the guidance on congenital heart disease
Check the guidance on fits, convulsions and seizures Check the guidance on coronary artery bypass or disease Check the guidance on heart attacks and angioplasty
Check the guidance on eye conditions Check the guidance on cystic fibrosis
D
Check the guidance on deafness Check the guidance on defibrillators Check the guidance on deja vu
Check the guidance on dementia Check the guidance on depression Check the guidance on diabetes
Check the guidance on dilated cardiomyopathy Check the guidance on eye conditions Check the guidance on dizziness (including vertigo)
Check the guidance on drug misuse
E
Check the guidance on eating disorders Check the guidance on brain empyemas
Check the guidance on seizures and epilepsy Check the guidance on essential tremors Check the guidance on eye conditions
F
Check the guidance on blackouts and fainting Check the guidance on fits, convulsions and seizures Check the guidance on head injuries
Check the guidance on ataxia, including Friedrich's ataxia
G
Check the guidance on eye conditions Check the guidance on global amnesia
Check the guidance on seizures and epilepsy Check the guidance on Guillain Barré syndrome
H
Check the guidance on head injuries
Check the guidance on heart attacks and angioplasty Check the guidance on arrhythmias Check the guidance on heart failure
Check the guidance on heart murmurs Check the guidance on heart palpitations
Check the guidance on high blood pressure Check the guidance on HIV Check the guidance on Hodgkin's lymphoma
Check the guidance on Huntington's disease Check the guidance on hydrocephalus Check the guidance on high blood pressure
Check the guidance on hypertrophic cardiomyopathy Check the guidance on hypoglycaemia Check the guidance on hypoxic brain damage
Check the guidance on surgery
I
Check the guidance on defibrillators Check the guidance on intracerebral haemorrhages
Check the guidance on ischaemic heart disease
K
Check the guidance on kidney dialysis (also known as renal dialysis Check the guidance on kidney problems
Check the guidance on Korsakoff's syndrome
L
Check the guidance on labyrinthitis Check the guidance on learning difficulties
Check the guidance on left bundle branch blocks Check the guidance on leukaemia Check the guidance on Lewy body dementia
Check the guidance on limb disability Check the guidance on Long QT syndrome Check the guidance on monocular vision
Check the guidance on hypoglycaemia Check the guidance on lumboperitoneal shunts Check the guidance on lung cancer
Check the guidance on lymphoma
M
Check the guidance on eye conditions Check the guidance on brain tumours
Check the guidance on malignant melanoma Check the guidance on bipolar disorder - previously known as manic depression Check the guidance on Marfan's syndrome
Check the guidance on medulloblastomas Check the guidance on severe memory problems Check the guidance on meningioma
Check the guidance on transient ischaemic attacks and mini-strokes Check the guidance on monocular vision Check the guidance on motor neurone disease
Check the guidance on multiple sclerosis Check the guidance on muscular dystrophy Check the guidance on myasthenia gravis
Check the guidance on heart attacks and angioplasty Check the guidance on myoclonus
N
Check the guidance on narcolepsy
Check the guidance on eye conditions Check the guidance on excessive sleepiness
Check the guidance on eye conditions
P
Check the guidance on pacemakers
Check the guidance on heart palpitations Check the guidance on paranoia Check the guidance on paranoia
Check the guidance on paraplegia Check the guidance on Parkinson's disease Check the guidance on peripheral arterial disease
Check the guidance on peripheral neuropathy Check the guidance on personality disorders Check the guidance on seizures and epilepsy
Check the guidance on pituitary tumours Check the guidance on PTSD Check the guidance on psychosis
Check the guidance on psychotic depression Check the guidance on pulmonary arterial hypertension
R
Check the guidance on kidney dialysis (also known as renal dialysis
Check the guidance on transient ischaemic attacks and mini-strokes Check the guidance on eye conditions Check the guidance on eye conditions
S
Check the guidance on schizo-affective disorders Check the guidance on schizophrenia Check the guidance on scotoma
Check the guidance on fits, convulsions and seizures Check the guidance on severe communication disorders Check the guidance on severe depression
Check the guidance on monocular vision Check the guidance on excessive sleepiness Check the guidance on excessive sleepiness
Check the guidance on spinal problems Check the guidance on strokes Check the guidance on subarachnoid haemorrhages
Check the guidance on surgery Check the guidance on blackouts and fainting
T
Check the guidance on tachycardia
Check the guidance on seizures and epilepsy Check the guidance on seizures and epilepsy Check the guidance on Tourette's syndrome
Check the guidance on global amnesia Check the guidance on transient ischaemic attacks and mini-strokes Check the guidance on eye conditions
U
V
Check the guidance on heart valve disease or replacement valves Check the guidance on defibrillators
Check the guidance on dizziness (including vertigo) Check the guidance on monocular vision Check the guidance on eye conditions Check the guidance on eye conditions
W
Wolff-Parkinson-White syndrome
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
19 hours ago
- Daily Mail
Warning over 'two tier' support for ADHD sufferers amid 'significant' rise in the use of unregulated private providers
NHS waiting lists for ADHD diagnosis and support have led to a 'significant' rise in the use of unregulated private providers, a report has said. The ADHD Taskforce, commissioned by NHS England with the support of the Government, has published an interim report calling for the system of diagnosing and managing the neurological condition to be overhauled. ADHD (attention deficit hyperactivity disorder) is characterised by patterns of restlessness, impulsivity and difficulty concentrating on one thing, with assessment and treatment typically provided by highly specialised doctors. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Experts said waiting times for NHS ADHD services 'have escalated and are unacceptably long', with demand on services 'very likely' to continue to rise. Professor Anita Thapar, chair of the ADHD Taskforce, said: 'We need to get this right – to make sure people get early diagnosis and support.' A Department of Health and Social Care spokesman said: 'The report into the state of the NHS laid out how severe the delays have become for people waiting for an attention deficit hyperactivity disorder diagnosis.'
The Independent
a day ago
- The Independent
Breast cancer survivors may have a lower risk of Alzheimer's disease, experts say
Could breast cancer survivors have a lower risk of Alzheimer's disease South Korean researchers say breast cancer survivors have an 8 percent lower risk of developing the condition compared to people without cancer, despite commonly-held concerns about cognitive decline following treatment. 'We found a slightly lower risk of [Alzheimer's] among breast cancer survivors, in line with several previous studies and a meta-analysis,' the authors wrote in a study published Friday in the journal JAMA Network Open, the open-access journal of the American Medical Association. 'This suggests that standard breast cancer treatments, including radiation therapy, may not increase and may even reduce Alzheimer's dementia risk in the short term,' Seoul National University Dr. Su-Min Jeong, who led the study, told AuntMinnie. 'Clinicians can use this evidence to reassure breast cancer patients concerned about their cognitive health.' The researchers also found no association between the risk for Alzheimer's and treatment with chemotherapeutic agents. 'An increased risk of dementia in patients with head and neck cancer treated with radiation therapy was noted. However, the risk of AD could differ, depending on the dose of radiation and site of exposure,' they explained. To reach these conclusions, they looked at the data from more than 70,000 patients who underwent breast cancer surgery between the first day of January 2010 and the last day of December 2016. The data was collected by the Korean National Health Insurance Service. Participants were grouped with healthy age-matched controls at a one-to-three ratio. The women underwent an average follow-up of 7.3 years. Among the participants, 1,229 cases of Alzheimer's were detected. Breast cancer survivors showed a slightly lower risk of developing Alzheimer's compared with cancer-free women. The trend was especially applicable to women aged 65-and-up. 'However, landmark analyses found that this lower risk did not persist beyond five years of survival. Cancer treatment with radiation therapy was associated with reduced risk of [Alzheimer's] among survivors,' they wrote. They say that further research is needed to assess the long-term risk of Alzheimer's disease in breast cancer survivors. Previous research from researchers at the University of Pittsburgh also found that hormone modulating therapy used for the treatment of breast cancer was associated with a 7 percent lower risk of developing Alzheimer's disease and related dementias later in life, and that some women may be at a higher risk than others. The South Korean researchers noted that cytotoxic chemotherapy has been recognized as a cause of cognitive decline called chemobrain in cancer survivors, referring to thinking and memory issues after treatment. Researchers added that their findings suggest that this treatment does not directly lead to Alzheimer's disease.
Rhyl Journal
a day ago
- Rhyl Journal
ADHD waiting list led to rise in unregulated private providers
The ADHD taskforce, commissioned by NHS England with the support of the Government, has published an interim report saying the system for diagnosing and managing ADHD needs to be overhauled. At the moment, ADHD assessment and treatment in England is provided by highly specialised doctors in secondary care. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Experts behind the study said waiting times for NHS ADHD services 'have escalated and are unacceptably long' and demand on services is 'very likely' to continue to rise. The taskforce concluded that ADHD is not solely the remit of the NHS and other health providers, with schools being vital for identifying and meeting needs at an early stage. And while a clinical diagnosis of ADHD via the NHS is required if a person needs medication, early support can still be provided to others. The report said: 'We need timely recognition and early support of suspected ADHD and neurodivergence across all settings. 'This is especially important in schools and the early years, to prevent adverse impacts and costly outcomes in the future. This should be needs-led and not require a clinical diagnosis.' The report also suggested there is no evidence of over-diagnosis of ADHD in the UK. It argued: 'England and the rest of the UK have much lower service recognition and treatment rates of ADHD diagnosis compared with other European countries. 'Recent data show a very high level of under-recognition and under-treatment of strictly diagnosed ADHD, with significant inequalities in access to care.' The report also addressed concerns about potential 'over-medicalisation and over-diagnosis', including worries that people are self-diagnosing ADHD based on information from social media. However, the report, said that 'currently there is no good evidence on what percentage of those waiting to see a clinician have self-diagnosed ADHD using social media and eventually meet or do not meet ADHD diagnostic criteria after a high-quality assessment. 'We only know currently that in England, recognised rates of ADHD are lower than the expected prevalence of ADHD.' Currently, the estimated economic costs of not treating ADHD are around £17 billion to the UK economy, the report went on. This includes through lower tax contributions, people needing state benefits and more likely to be not in education, employment or training, or who are long-term unemployed. 'Many of these costs are avoidable, as with appropriate, early support, people with ADHD can thrive,' it said. Professor Anita Thapar, chair of the ADHD Taskforce, said: 'The recommendations put forward by the taskforce will require action across Government and cross-sector organisations to make the necessary changes to improve the lives of people with ADHD. 'We need to get this right, to make sure people get early diagnosis and support, not just in the NHS but across society.' Dr Adrian James, NHS England's medical director for mental health and neurodiversity, said: 'We know that too many people with ADHD have been waiting for too long for support, which is why we launched the taskforce last year to help respond to the significant growth in the need for care. 'It is clear that much more needs to be done to improve ADHD assessment and care in England and ensure people can get a timely diagnosis, and we welcome the findings from the interim report, and look forward to its final conclusions later this year.' A Department of Health and Social Care spokesperson said: 'Lord Darzi's report into the state of the NHS laid out how severe the delays have become for people waiting for an attention deficit hyperactivity disorder diagnosis. 'We welcome the publication of the ADHD Taskforce's interim report, which provides valuable insights into the challenges affecting those with ADHD, including access to services and support.' The NHS has launched publicly-available data collection on ADHD referrals and waiting times to help local teams better understand how they are performing. By March 2026, the Government also aims for six in 10 pupils to have access to a mental health support team in school.
